José de Jesús Garduño‐García

Author

Also Known As

Gabriel G. Huitrón-Bravo, Garduño-García, José de Jesús, J. J. Garduño-García, J. d. J. Garduno, JESUS GARDUNO-GARCIA, Jesús Garduño-Garcia, Jose De Jesus Garduno Garcia, Jose J. Garduño-Garcia, Jose de Jesus Garduno Garcia, Jose de Jesus Garduno-Garcia

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Mexican Social Security Institute The University of Texas Health Science Center at San Antonio Universidad Autónoma del Estado de México Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Universidad Nacional Autónoma de México

About

José de Jesús Garduño‐García is an author at Mexican Social Security Institute specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	206
2	Public Health	3	3	97
3	Health Sciences	2	2	79
4	Biostatistics	1	1	69
5	Cellular Physiology	1	1	30

José de Jesús Garduño‐García

Publications

944

Citations

H-Index

Page 1

	Year	Citations
TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects José de Jesús Garduño‐García, Ulices Alvirde-García, Guadalupe López-Carrasco, European Journal of Endocrinology	2010	269
Reduction in Reactive Oxygen Species Production by Mitochondria From Elderly Subjects With Normal and Impaired Glucose Tolerance Sangeeta Ghosh, Raweewan Lertwattanarak, Natalie Lefort, Diabetes	2011	126
Dietary patterns associated with body mass index (BMI) and lifestyle in Mexican adolescents Laura E. Gutiérrez-Pliego, Eneida Camarillo-Romero, Laura Patricia Montenegro-Morales, BMC Public Health	2016	73
Prediction of incident hypertension and arterial stiffness using the non–insulin‐based metabolic score for insulin resistance (METS‐IR) index Omar Yaxmehen Bello‐Chavolla, Neftalí Eduardo Antonio-Villa, Arsenio Vargas‐Vázquez, Journal of Clinical Hypertension HypertensionObesityMetabolic SyndromeDiabetes EpidemiologyBiostatistics	2019	69
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes Carolina Solis‐Herrera, Curtis Triplitt, José de Jesús Garduño‐García, Diabetes Care	2013	60
Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort Olimpia Arellano‐Campos, Donají Gómez‐Velasco, Omar Yaxmehen Bello‐Chavolla, BMC Endocrine Disorders	2019	54
Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk Neftalí Eduardo Antonio-Villa, Omar Yaxmehen Bello‐Chavolla, Arsenio Vargas‐Vázquez, Nutrition Metabolism and Cardiovascular Diseases Insulin ResistanceMetabolic SyndromeObesityHypertensionInsulin Signaling	2020	43
Insulin and Leptin Levels in Obese Patients With and Without Breast Cancer María del Socorro Romero-Figueroa, José de Jesús Garduño‐García, Jesús Duarte-Mote, Clinical Breast Cancer ObesityMetabolic SyndromeInsulin SignalingBody CompositionMetabolic Disorder	2013	36
A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle Sophie E. Hussey, Helen Lum, A. Villanueva Alvarez, Diabetologia InflammationToll-like ReceptorsPlasma NefaHuman MuscleMolecular Physiology	2013	30
A low dose lipid infusion is sufficient to induce insulin resistance and a pro-inflammatory response in human subjects Hanyu Liang, Helen Lum, A. Villanueva Alvarez, PLoS ONE	2018	28

Page 1